Sri Lanka, Aug. 5 -- A total of 39 drugs have failed quality tests so far in 2026, according to the Medical Supplies Division of the Health Ministry.

Of the drugs that failed the tests, 18 were manufactured in India, while four were locally produced. The remaining drugs originated from China, Bangladesh. France, Netherland and Ireland

Among the drugs identified as substandard, some have been withdrawn, withheld, or discontinued, the Health Ministry said.

The Ministry further noted that a total of 650 drug quality failures have been recorded since 2017. The highest number of such cases, 96, was reported in 2019, while 86 drugs failed quality tests in 2022.

Drug quality concerns came under intense public scrutiny in 2023 following repor...